新型组胺H1受体拮抗剂——咪唑斯汀

被引：49

作者：

陈志强

徐文严

机构：

[1] 中国医学科学院、中国协和医科大学皮肤病研究所!南京

来源：

中华皮肤科杂志 | 2001年 / 02期

关键词：

咪唑斯汀; 安慰剂; 空白剂; H1; 咪唑乙胺; 组胺; 受体拮抗剂;

D O I：

暂无

中图分类号：

R976 [抗变态反应药物];

学科分类号：

摘要：

引用

页码：66 / 68

页数：3

共 5 条

[1]

Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression—Inhibitory effects of anti-inflammatory drugs[J] . Bettina Wedi,Vera Novacovic,Michael Koerner,Alexander Kapp.The Journal of Allergy and Clinical Immunology . 2000 (3)

[2] Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis [J].

Scadding, GK ;

Tasman, AJ ;

Murrieta-Aguttes, M ;

Bachert, C .

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1999, 27 (06) :273-285

[3]

Variations among non-sedating antihistamines: are there real differences?[J] . Mauri J. Mattila,Ilari Paakkari.European Journal of Clinical Pharmacology . 1999 (2)

[4]

Lack of interaction between two antihistamines, mizolastine and cetirizine, and ethanol in psychomotor and driving performance in healthy subjects[J] . A. Patat,N. Ulliac,I. Zieleniuk,D. Stubbs,C. Dunmore,B. Sexton,A. Irving,W. Jones.European Journal of Clinical Pharmacology . 1995 (2)

[5]

Mizolastine: a review of its use in allergic rhinitis and chronic idiopathic urticaria. Prakash A, Lamb HM. BioDrugs . 1998

← 1 →